Stephane Peluso - 11 Jan 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Chief Scientific Officer
Signature
/s/Stephane Peluso
Issuer symbol
N/A
Transactions as of
11 Jan 2022
Net transactions value
$0
Form type
4
Filing time
12 Jan 2022, 16:00:45 UTC
Previous filing
03 Aug 2021
Next filing
04 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option(right to buy) Award $0 +87,027 $0.000000 87,027 11 Jan 2022 Common Stock 87,027 $1.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/48th of the shares on January 31, 2022 and vests as to 1/48th of the shares at the end of each calendar month thereafter.